28.58 F
New York
January 28, 2022

PFIZER

EU drug regulator OKs Pfizer COVID pill for high-risk patients

Reuters
by Reuters00
Jan 27 (Reuters) – The European Union’s drug regulator on Thursday gave the green light to Pfizer Inc’s (PFE.N) antiviral COVID-19 pill for treating adults at risk of severe illness, as the region scrambles to boost its arsenal to fight the Omicron variant. The endorsement by the European Medicines Agency......
Read more

Pfizer and BioNTech start trials of new Omicron-specific jab

BBC
by BBC00
“Staying vigilant against the virus requires us to identify new approaches for people to maintain a high level of protection, and we believe developing and investigating variant-based vaccines, like this one, are essential in our efforts towards this goal,” said Kathrin U. Jansen, senior vice-president and head of vaccine research......
Read more

Pfizer opens study of COVID shots updated to match omicron

Detriot News
by Detriot News00
Detroit News – For more and to sign up click here Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious omicron variant. Pfizer and its partner BioNTech announced the study on Tuesday. COVID-19 vaccine makers have been updating their shots to......
Read more

Pfizer and BioNTech launch clinical study of Covid vaccine targeting omicron

CNBC
by CNBC023
CNBC – For more and to sign up click here A ten year old child receives the Pfizer-BioNTech Covid-19 Vaccine for 5-11 year old kids at Hartford Hospital in Hartford, Connecticut on November 2, 2021. Joseph Prezioso | AFP | Getty Images Pfizer and BioNTech on Tuesday launched a clinical......
Read more

Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots – study

Reuters
by Reuters00
Vials of Chinese Sinovac’s CoronaVac vaccine against coronavirus disease (COVID-19) pictured inside the newly inaugurated production lab designated to manufacture the vaccine, in Constantine, Algeria September 29, 2021. REUTERS/Ramzi Boudina Register now for FREE unlimited access to Reuters.com Register Jan 24 (Reuters) – A third booster dose of a COVID-19......
Read more

Pfizer CEO sees annual COVID vaccine rather than frequent boosters

Reuters
by Reuters00
JERUSALEM, Jan 22 (Reuters) – Pfizer Inc (PFE.N) Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic. Pfizer/BioNtech’s (22UAy.DE) COVID-19 vaccine has shown to be effective against severe disease and death caused by the......
Read more

Pfizer CEO awarded $1M Genesis Prize for role in development of COVID-19 vaccine

CBS News
by CBS News00
CBS News – For more and to sign up click here Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded on Wednesday the prestigious Genesis Prize for his efforts in leading the development of a COVID-19 vaccine. The $1 million award is granted each year......
Read more

Pfizer says its vaccine targeting Omicron will be ready in March

CBS News
by CBS News00
CBS News – For more and to sign up click here Pfizer will have a COVID-19 vaccine that specifically targets the Omicron variant ready by March, the pharmaceutical company’s chief executive said Monday.  Pfizer CEO Albert Bourla said the company has already begun manufacturing a new version of its COVID-19......
Read more

A universal flu vaccine may be the next big mRNA breakthrough for Moderna, Pfizer

CNBC
by CNBC025
CNBC – For more and to sign up click here Employees in special suits test the procedures for the manufacturing of the messenger RNA (mRNA) for the Covid-19 vaccine in German company BioNTech, in Marburg, Germany on March 29, 2021. Abdulhamid Hosbas | Anadolu Agency | Getty Images The research......
Read more

Pfizer CEO says omicron vaccine will be ready in March

CNBC
by CNBC032
CNBC – For more and to sign up click here Pfizer CEO Albert Bourla on Monday said a vaccine that targets the omicron variant of Covid will be ready in March, and the company’s already begun manufacturing the doses. “This vaccine will be ready in March,” Bourla told CNBC’s Squawk......
Read more

CDC panel recommends Pfizer boosters for 12- to 15-year-olds amid omicron surge

CNBC
by CNBC054
CNBC – For more and to sign up click here A nurse gives Sherri Trimble, 15, a shot of the vaccine at a vaccination clinic at Health First Medical Centre in Melbourne, Florida. Paul Hennessy | SOPA Images | LightRocket | Getty Images The Centers for Disease Control and Prevention’s......
Read more

U.S. tops one million daily COVID cases

CBS News
by CBS News00
CBS News – For more and to sign up click here U.S. tops one million daily COVID cases – CBS News Watch CBSN Live More than one million new COVID cases were reported Monday, a new single-day record for the U.S. Hospitalizations and childhood infections are also setting pandemic records.......
Read more

U.S. doubling and accelerating order of Pfizer antiviral pills

CBS News
by CBS News00
CBS News – For more and to sign up click here President Biden announced on Tuesday that he’s directing his team to double the United States’ order of Pfizer antiviral pills from 10 million COVID-19 treatment courses to 20 million treatment courses, and the delivery will be accelerated from September......
Read more

FDA expands Pfizer booster eligibility to kids ages 12 to 15, authorizes third shots at 5 months

CNBC
by CNBC056
CNBC – For more and to sign up click here Dash Hunger, 12, receives the Pfizer-BioNTech Covid-19 Vaccine at the Jewish Federation/JARC’s offices in Bloomfield Hills, Michigan, on May 13, 2021. Jeff Kowalsky | AFP | Getty Images The Food and Drug Administration on Monday expanded eligibility for Pfizer and......
Read more

Stocks making the biggest moves midday: Pfizer, Peloton, Carnival and more

CNBC
by CNBC09
CNBC – For more and to sign up click here Paxlovid, a Pfizer’s coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer | Handout | via Reuters Check out the companies making headlines in midday trading.......
Read more

Sinovac COVID-19 shot with Pfizer booster less effective against Omicron – study

Reuters
by Reuters00
The Sinovac vaccine is pictured at StarMed Specialist Centre, a private medical centre, in Singapore July 13, 2021. REUTERS/Caroline Chia Register now for FREE unlimited access to Reuters.com Register Dec 31 (Reuters) – Sinovac’s two-dose COVID-19 vaccine followed by a booster Pfizer-BioNTech shot showed a lower immune response against the......
Read more

COVID-19 pills could be a game changer — if you can get your hands on them

CBS News
by CBS News00
CBS News – For more and to sign up click here COVID-19 patients in Wyoming eager to get their hands on Pfizer’s new antiviral pill for treating the disease may want to draw straws. With supplies extremely limited for now, the Biden administration initially will provide the state with only......
Read more

New Zealand links 26-year-old man’s death to Pfizer COVID-19 vaccine

Reuters
by Reuters00
A vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/File Photo Register now for FREE unlimited access to Reuters.com Register SYDNEY, Dec 20 (Reuters) – New Zealand authorities on Monday said they had linked a 26-year-old man’s death......
Read more

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More